Checkpoint Therapeutics stockholders approve merger with Sun Pharma; closing expected May 30, 2025

Checkpoint Therapeutics, Inc.

Unaffiliated stockholders voted 42,951,131 For, 823,995 Against, 154,463 Abstain to adopt Merger Agreement.
Statutory merger approval: 149,819,859 For, 823,995 Against, 154,463 Abstain; compensation proposal also approved.
Closing of merger with Sun Pharma anticipated on or about May 30, 2025, subject to other conditions.
Merger sub will merge into Checkpoint; Checkpoint will survive as wholly owned subsidiary of Sun Pharma.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.